The approval of the European Medicines Agency (EMA) for vaccines adapted to deal with the Omicron variant could arrive “in April-May”. This was stated by the head of the Ema vaccination strategy, Marco Cavaleri, responding to a question from ANSA, specifying that it is still necessary to analyze whether a “global discussion” on new doses is necessary and whether “pursuing the virus instead of anticipating it” is “the right strategy in the interest of public health”.
“A discussion is emerging on the possibility of administering a second booster dose with the same vaccines currently in use: no data has yet been generated to support this approach,” Cavaleri also said. “If the use of boosters could be considered part of a contingency plan, repeated vaccinations at short intervals would not be a sustainable long-term strategy,” he noted. The new data on vaccines – he said – are very reassuring and show that they reduce the risk of hospitalization and death during pregnancy without causing complications or harming the unborn child “.
.
Source From: Ansa
I have been working in the news industry for over 10 years now and I have worked for some of the biggest news websites in the world. My focus has always been on entertainment news, but I also cover a range of other topics. I am currently an author at Global happenings and I love writing about all things pop-culture related.
